Biologically active filters – An advanced water treatment process for contaminants of emerging concern

Document Type

Article

Publication Date

1-1-2017

Abstract

With the increasing concern of contaminants of emerging concern (CECs) in source water, this study examines the hypothesis that existing filters in water treatment plants can be converted to biologically active filters (BAFs) to treat these compounds. Removals through bench-scale BAFs were evaluated as a function of media, granular activated carbon (GAC) and dual media, empty bed contact time (EBCT), and pre-ozonation. For GAC BAFs, greater oxygen consumption, increased pH drop, and greater dissolved organic carbon removal normalized to adenosine triphosphate (ATP) were observed indicating increased microbial activity as compared to anthracite/sand dual media BAFs. ATP concentrations in the upper portion of the BAFs were as much as four times greater than the middle and lower portions of the dual media and 1.5 times greater in GAC. Sixteen CECs were spiked in the source water. At an EBCT of 18 min (min), GAC BAFs were highly effective with overall removals greater than 80% without pre-ozonation; exceptions included tri(2-chloroethyl) phosphate and iopromide. With a 10 min EBCT, the degree of CECs removal was reduced with less than half of the compounds removed at greater than 80%. The dual media BAFs showed limited CECs removal with only four compounds removed at greater than 80%, and 10 compounds were reduced by less than 50% with either EBCT. This study demonstrated that GAC BAFs with and without pre-ozonation are an effective and advanced technology for treating emerging contaminants. On the other hand, pre-ozonation is needed for dual media BAFs to remove CECs. The most cost effective operating conditions for dual media BAFs were a 10 min EBCT with the application of pre-ozonation.

Identifier

85013192599 (Scopus)

Publication Title

Water Research

External Full Text Location

https://doi.org/10.1016/j.watres.2017.02.014

e-ISSN

18792448

ISSN

00431354

PubMed ID

28226247

First Page

31

Last Page

41

Volume

114

This document is currently not available here.

Share

COinS